$ELUT News

Elutia Inc. 2026 Q1 - Results - Earnings Call Presentation

Elutia Inc. (ELUT) Q1 2026 Earnings Call Transcript

Elutia Reports Q1 2026 Results: Full Earnings Call Transcript

Elutia Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $3.114M Beat $3.000M Estimate

Elutia to Present at Sidoti’s Small-Cap Virtual Investor Conference March 18-19

Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Elutia Inc. 2025 Q4 - Results - Earnings Call Presentation

Elutia Inc. Q4 2025 Earnings Call Summary

Elutia (ELUT) Q4 2025 Earnings Call Transcript

Elutia Inc (NASDAQ:ELUT) Reports Q4 Revenue Miss Amid Key FDA Submission for NXT-41

Elutia Inc. (ELUT) Q4 2025 Earnings Call Transcript

Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process

Elutia Q4 EPS $(0.14), Inline, Sales $3.271M Miss $3.300M Estimate

Exploring Elutia's Earnings Expectations

Elutia Regains Compliance with Nasdaq Listing Requirements

Elutia Regains Nasdaq Compliance

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026

Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™

Insider Spends US$74k Buying More Shares In Elutia